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Objective: To examine associations between intake of simple sugars and cancer incidence, cancer mor-
tality, and total mortality in a prospective cohort study based on the PREDIMED trial conducted from
2003 to 2010.
Methods: Participants were older individuals at high cardiovascular risk. Exposures were total sugar,
glucose and fructose from solid or liquid sources, and fructose from fruit and 100% fruit juice. Cancer
incidence was the primary outcome; cancer mortality and all-cause mortality were secondary outcomes.
Multivariable-adjusted, time-dependent Cox proportional hazard models were used.
Results: Of 7447 individuals enrolled, 7056 (94.7%) were included (57.6% women, aged 67.0 ± 6.2 years).
534 incident cancers with 152 cancer deaths and 409 all-cause deaths were recorded after a median
follow-up of 6 years. Intake of simple sugars in solid form was unrelated to outcomes. Higher canceriovascular disease; CI, confidence interval; FFQ, food frequency questionnaire; HRs, hazard ratios; MUFAs, mono-
acids; PREDIMED, PREvencion con DIeta MEDiterranea; SFAs, saturated fatty acids; SSB, sugar-sweetened beverages.
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J.C. Laguna, M. Alegret, M. Cofan et al. Clinical Nutrition 40 (2021) 5269e5277incidence was found per 5 g/day increase in intake of liquid sugars, with multivariable-adjusted HR of
1.08 (95% CI, 1.03e1.13) for total liquid sugar, 1.19 (95% CI, 1.07e1.31) for liquid glucose, 1.14 (95% CI, 1.05
e1.23) for liquid fructose, and 1.39 (95% CI, 1.10e1.74) for fructose from fruit juice. Cancer and all-cause
mortality increased to a similar extent with intake of all sugars in liquid form. In categorical models,
cancer risk was dose-related for all liquid sugars.
Conclusions: Simple sugar intake in drinks and fruit juice was associated with an increased risk of overall
cancer incidence and mortality and all-cause mortality. This suggests that sugary beverages are a
modifiable risk factor for cancer and all-cause mortality.
© 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The prevalence of obesity and type-2 diabetes are increasing
globally [1,2], and there is accumulating evidence that these two
conditions are associated with the incidence of some types of
cancer. In 2012, 5.7% of incident cancers worldwide, amounting to
nearly 800,000 new cases, were attributable to the combined ef-
fects of diabetes and a high body mass index (BMI) [3]. Cancer-
related mortality is also increased in patients with diabetes
compared to non-diabetics [4]. Independently of diabetes status,
overweight and obesity are strongly associated with cancer risk
[5,6].
Sugar-sweetened beverages (SSB) are an important contributor
to the “diabesity” epidemic. SSB intake promotes weight gain, as
energy compensation does not work equally well with liquid than
solid foods [7]. Given the strong link of sugary drinks with obesity
and diabetes [8,9], there has been an increasing interest in the
putative cancer risk of SSB and fructose intake [10,11]. A recent
systematic review of longitudinal studies [12] indicated that there
was no clear association between total sugar intake and cancer risk.
Similarly, the 2018 report of the World Cancer Research Fund/
American Institute for Cancer Research on nutrition and cancer
concluded that evidence was not sufficient to support a link be-
tween sugar intake and cancer risk [13]. Concerning sugars and
cancer-related mortality, data from large prospective studies are
inconclusive, as no association [14], a weak positive association
[15], and a U-shaped relationship [16] have been reported.
We hypothesized that simple sugar intake would be associated
with cancer incidence and mortality in individuals at high risk.
Therefore, we assessed the association of intake of sugars by source
with these outcomes, as well as cardiovascular disease (CVD) and
all-cause mortality, in a population at high risk because of old age
and high prevalence of obesity and diabetes, drawn from the
PREvencion con DIeta MEDiterranea (PREDIMED) study [17].
2. Material and methods
The PREDIMED study is a multicenter, randomized clinical trial
testing the efficacy of Mediterranean diets enriched with extra-
virgin olive oil or mixed nuts against a control diet for the pri-
mary prevention of CVD in older individuals at high cardiovascular
risk [18,19]; results on the main outcome have been published [17].
2.1. Study subjects
We used data from the PREDIMED study [17] considered as a
prospective cohort. PREDIMED enrolled 7447 participants, aged
55e80 years, with 57% women. The recruitment took place be-
tween October 2003 and June 2009. The trial was completed in
December 2010; endpoints for the present analysis were based on
an extended follow-up until June 2012. Data were analyzed from
January 22 to September 3, 2020.52702.2. Measurements and assessment of confounders
Information about medical, socio-demographic, anthropo-
metric, and lifestyle variables was obtained at baseline and updated
yearly. The validated Spanish version of the Minnesota question-
naire was used to assess leisure-time physical activity [20,21]; time
spent in several activities in minutes/d was multiplied by its typical
energy expenditure, expressed in metabolic equivalent tasks
(METs). Dietary habits were collected at baseline and yearly via a
validated semi-quantitative food frequency questionnaire (FFQ)
[22] administered in face-to-face interviews by trained dieticians.
The FFQ included 137 food items, and frequencies of consumption
were reported on an incremental scale with 9 levels (never or
almost never; 1e3 times/month; 1, 2e4, and 5e6 times/week; and
1, 2e3, 4e6, and >6 times/day). The estimated daily energy and
nutrient intake of each individual were calculated from intake
frequencies, weighted for portion sizes, using Spanish food
composition tables [23]. The reproducibility was assessed with
repeated FFQs using four 3-d diet records as references to examine
validity, as described [6]. The respective intraclass correlation co-
efficients for reproducibility and relative validity were 0.865 and
0.559 for glucose and 0.903 and 0.592 for fructose (P < 0.001).
Simple sugar intakewas estimated for each participant based on
total intake of sucrose and the monosaccharides glucose and
fructose, derived from their content in each food item. Sucrose was
the only disaccharide considered; as sucrose is split into fructose
and glucose in the intestinal lumen, the sucrose amount in grams
for each food item was divided by two and added to its content of
fructose and glucose, as appropriate. Consequently, three types of
sugar intake were considered: total sugar (fructose þ glucose),
fructose and glucose. Fructose in fruit juice was derived from re-
ported intakes of 100% fruit juice, usually from citrus fruits. As table
sugar, expressed as number of daily teaspoons, was a specific
question in the food frequency questionnaire (FFQ) [22], its asso-
ciation with outcomes was assessed separately.
2.3. Ascertainment of outcomes
Cancer incidence was a secondary outcome in the original study
protocol. All cancer sites, excluding non-melanoma skin cancer,
were included as relevant outcomes in the yearly interim analyses
prepared for the Data and Safety Monitoring Board of the PRE-
DIMED trial. Confirmation of incident cancer cases was based on
pathology or cytology reports (82%). Cases of cancer were other-
wise accepted when strong clinical and radiological or laboratory
marker evidence was available. All outcomes were reported to the
endpoint adjudication committee, whosemembers were blinded to
treatment allocation and sugar intake. The committee confirmed
major events, determined the cause of death, and updated yearly
information on these endpoints. The endpoints for the present
study were total cancer incidence and cancer mortality, CVD mor-
tality, and all-cause mortality. Outcomes were ascertained through
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records, and consultation of the National Death Index. The medical
records of deceased participants were requested to determine the
cause of death. This allowed the assessment of mortality regardless
of attrition, thus mortality results were not affected by dropout
rates.2.4. Statistical analyses
Participants with prevalent cancer (n ¼ 159), total energy in-
takes beyond predefined limits (500e3500 kcal/d for women and
800e4000 kcal/d for men) (n ¼ 154), and those with incomplete
dietary information in the FFQ (n ¼ 78) were excluded from ana-
lyses (Fig. 1). To take advantage of the repeated measurements of
food consumption, we used yearly updated measures of simple
sugar intake with data from baseline to the last FFQ before the
occurrence of pre-specified outcomes.
Follow-up time was calculated as the interval between the date
of randomization and the date of cancer diagnosis, death, or end of
follow-up (the date of the last visit or the last recorded clinical
event of participants while still alive), whichever came first. Cancer
incidence was the primary outcome for this prospective study.
Cancer mortality, CVD mortality, and all-cause mortality were
secondary outcomes. Cox regression models were used to assess
the relationship between simple sugar intake and the subsequent
incidence of any type of cancer, and cancer, CVD and all-cause
mortality. Sugar intakes were modeled as continuous variables
and hazard ratios (HRs) and their 95% confidence intervals (CIs) for
each outcome were calculated per increases in total sugar, glucose,
fructose and fructose in fruit juice of 5 g/d, which corresponds to
z50 mL of an SSB for total liquid sugar andz100 mL for individual
liquid sugars. Additionally, HRs was calculated per each increase in
1 teaspoon/d of table sugar (1 teaspoon ¼ 5 g of sugar). Regression
models were constructed for intake of total sugar, glucose and
fructose in solid foods; and total sugar, glucose, and fructose in
liquid foods, as well as fructose from fruit, fructose in 100% fruit
juice, and teaspoons of table sugar. We categorized solid sugar
intake into quartiles, assigning the reference category to the first
quartile, and liquid sugar intake into tertiles of participants with
any intake, as there were many with zero intakes (reference cate-
gory). The median values of each category were modeled as
continuous variables to examine linear trends. Multivariable
regression models were stratified by recruitment center and
adjusted for sex, age, history of diabetes (yes/no), history of hy-
pertension (yes/no), history of dyslipidemia (yes/no), smoking
habit (never, current and former), BMI, total energy intake, alcohol
intake, physical activity (METs/min/d), aspirin intake (yes/no),
vitamin supplementation (yes/no), family history of cancer (yes/
no), salt intake (g/day), red meat consumption (g/day), processed
meat consumption (g/day), adherence to Mediterranean diet score
(0e14 points), intervention group, and yearly (time-dependent
variable) change in simple sugar intake. In PREDIMED there were
small departures from the individual randomization protocol, as
425 members of the same household of a previously randomized
participant were directly allocated to the same intervention arm
and 441 participants from one of the 11 recruiting centers (site D)
were allocated by clusters (clinics) instead of using individual
randomization [3]. To account for intra-cluster correlations, we
additionally adjusted Cox models for robust variance estimators,
considering as clusters themembers of the same household and the
participants in the same clinics of site D.
We further estimated cancer risk when liquid sugars were
replaced by other nutrients in energy-density models that included5271total energy intake, saturated fatty acids (SFAs), trans fatty acids,
monounsaturated fatty acids (MUFAs), polyunsaturated fatty acids
(PUFAs), total protein, sugar from solid sources, complex carbohy-
drates, and alcohol. By leaving liquid sugars out of the model,
regression coefficients for the alternate nutrients can be interpreted
as the estimated effect of isocalorically substituting the nutrients of
interest for liquid sugars while holding total energy and other nu-
trients constant. Because energy intake and BMI and their changes
could be in the causal pathway between intake of liquid sugars and
outcomes, we performed sensitivity analyses by leaving energy
intake and baseline BMI out of themodels and also by controlling for
yearly-updated changes in energy intake and BMI.
All statistical tests were 2-sided, and P < 0.05 was considered
statistically significant. Analyses were conducted using SAS soft-
ware, version 9 (SAS Institute). Datawere analyzed from January 22
to March 11, 2020.3. Results
3.1. Patients and characteristics
Of the PREDIMED cohort of 7447 participants, 7056 (94.7%)
were included in the study, 4063 women (57.6%) and 2993 men
(42.4%), with a mean (SD) age of 67.0 (6.2) years. By study design,
there was a high prevalence of obesity (53.1%) and diabetes (49%).
Baseline characteristics of participants included in analyses were
similar to those of participants excluded, except for slightly
different intervention allocation rates (Table S1 in Supplementary
data). After a median follow-up of 6 years, 534 new cancers with
152 cancer deaths, 102 CVD deaths, and 409 all-cause deaths were
recorded. The site and frequency of documented cancers are
described in Table S2 in Supplementary data. Prostate, breast and
colorectal, in this order, were the most frequently diagnosed
cancer sites. Baseline characteristics of the total cohort and of
study subjects distributed in quartiles of total sugar intake are
presented in Table 1. Those with higher sugar intake were more
frequently women and had a higher prevalence of hypertension,
dyslipidemia and smoking, with higher Mediterranean diet score,
vitamin supplements, energy intake and physical activity levels,
but a lower frequency of diabetes and lower alcohol intake.
Baseline intake of simple sugars by source for the total population
and of study subjects distributed in quartiles of sugar intake is
depicted in Table 2. Intake of liquid sugars or fruit juice was low in
this older Mediterranean cohort: 57.5% of participants reported
any intake of total sugars in liquid form and 29.3% reported intake
of 100% fruit juice.3.2. Outcomes by sugar source
In multivariable-adjusted Cox models, total sugar intake
(Table S3 in Supplementary data) and simple sugar intake in solid
form, either as total solid sugar, solid glucose, solid fructose, or
fructose present in fruits, were unrelated to outcomes (Fig. S1 in
Supplementary data). In contrast, a 5 g/day increase in intake of
total liquid sugar, liquid glucose, liquid fructose, or fructose in
fruit juice was positively associated with cancer risk, cancer-
related mortality, and all-cause mortality (Fig. 2). For every
outcome, the highest risk was associated with intake of fructose
from fruit juice.
Table sugar intake was also associated with risk of all-cause
mortality (HR 1.07; 95% CI, 1.00e1.14 for each intake of 1
teaspoon/d) (Table S4 in Supplementary data).
Fig. 1. Flowchart depicting the selection of participants in the PREDIMED study included in the present analysis.
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liquid sugar intake. Cancer risk increased linearly with increasing
doses of liquid sugars. Compared with non-consumers, individuals
in the top category of intake of total liquid sugar, liquid glucose,
liquid fructose and fructose in fruit juice had significant increases in
cancer risk ranging from 30% to 51% in multivariable-adjusted
models. For liquid sugars, cancer and all-cause mortality
increased non-significantly in a dose-dependentmanner, except for
a significant increase in cancer mortality for liquid fructose. No
associations were observed for CVD mortality. Categories of solid
sugar intake were unrelated to outcomes (Table S5 in Supple-
mentary data). Participants in the highest category of table sugar
intake had higher cancer and all-cause mortality (Table S6 in
Supplementary data).
3.3. Substitution and sensitivity analyses
Results for themain substitution analyses are presented inTable 4.
Isocaloric replacement of liquid sugars by the other main nutrients
was associated with a 28%e36% reduction in cancer risk, which was
statistically significant for all nutrients except trans fatty acids.When
liquid sugars were replaced for MUFAs, sugars from solid sources or
complex carbohydrates, cancer mortality risk was significantly
reduced from 36% to 41%. Replacement of liquid sugars by PUFAs
reduced all-causemortality by 34% (Table S7 in Supplementary data).
The findings for liquid sugars and cancer risk were not materi-
ally changed when baseline energy intake and BMI were left out of5272the models or when we adjusted for yearly-updated changes in
energy intake and BMI (Table S8 in Supplementary data).
3.4. Subgroup analyses
In stratified analyses (Tables S9-S11 in Supplementary data), the
associations persisted in all subgroups except for an interaction
(P ¼ 0.016) on all-cause mortality between total liquid sugars and
dyslipidemia; the HRs per 5 g/day increase were 1.14 (95% CI,
1.07e1.21) among dyslipidemic participants vs. 0.96 (95% CI,
0.85e1.09) among those without dyslipidemia. Mutual adjustment
of the models for sugars from solid and liquid sources had no effect
on the observed associations (Tables S12 and S13 in Supplementary
data).
4. Discussion
In this prospective study of individuals at high risk of CVD and
cancer, we found a significant association of simple sugar intake in
liquid form (total sugar, glucose and fructose, including fructose
from fruit juice) with an increased risk of cancer incidence and
mortality. The association remained significant after adjustment for
the main recognized risk factors for cancer, as well as after
adjustment for daily energy intake and annual change in simple
sugar intake. The findings for cancer incidence were consistent
when assessed by categories of liquid sugar intake, for which linear
doseeresponse associations were observed. Cancer incidence and
Table 1
Baseline Characteristics of the 7056 Study Subjects by Total Sugar Intake quartiles.
Characteristic Total n ¼ 7056 47 g/day n ¼ 1764 >47 to 62.2 g/day
n ¼ 1757
>62.2 to 81.8 g/day n ¼ 1770 >81.8 g/day n ¼ 1765 P valuea
Men 2993 (42.4) 785 (44.5) 757 (43.1) 743 (42.0) 708 (40.1) 0.059
Age (years) 67.0 (6.2) 66.9 (6.2) 67.1 (6.3) 67.0 (6.2) 67.0 (6.2) 0.714
Body mass index (kg/m2) 29.97 (3.9) 30.06 (3.97) 29.97 (3.89) 29.96 (3.76) 29.89 (3.83) 0.642
Diabetes, n (%) 3455 (49.0) 768 (43.5) 834 (47.5) 932 (52.7) 1067 (60.5) <0.001
Hypertension, n (%) 5838 (82.7) 1444 (81.9) 1428 (81.3) 1460 (82.5) 1506 (85.3) 0.008
Dyslipidemia, n (%) 5098 (72.3) 1210 (68.6) 1239 (70.5) 1287 (72.7) 1362 (77.2) <0.001
Family history of cancer, n (%) 3466 (49.1) 806 (45.7) 869 (48.5) 873 (49.3) 918 (52) 0.003
Smoking habit, n (%) 0.002
Never 4341 (61.5) 1018 (57.7) 1077 (61.3) 1107 (62.5) 1139 (64.5)
Current 985 (14.0) 287 (16.3) 244 (13.9) 228 (12.9) 226 (12.8)
Former 1730 (24.5) 459 (26.0) 436 (24.8) 435 (24.6) 400 (22.7)
Total energy intake (kcal/day) 2238 (544) 1960 (490) 2129 (491) 2302 (488) 2559 (518) <0.001
Alcohol Intake (g/day) 8.3 (14.1) 9.7 (16.2) 8.7 (15.4) 7.7 (12.4) 7.3 (11.8) <0.001
Na (mg/day) 2361 (846) 2145 (830) 2280 (817) 2423 (822) 2593 (849) <0.001
Red meat (gr/day) 48.5 (35.9) 48.2 (38.5) 47.8 (33.4) 50.9 (36.3) 47.1 (35.3) 0.010
Processed meat (gr/day) 26.1 (19.4) 24.5 (19.8) 25.6 (17.3) 27.2 (20.5) 27.1 (21.4) <0.001
Total physical activity (METs/min/day) 230.1 (237.9) 201.3 (223.9) 227.4 (229.1) 243.6 (245.5) 248.2 (249.4) <0.001
Intervention group, n (%) 0.103
Mediterranean diet þ EVOO 2427 (34.4) 588 (33.3) 616 (35.1) 582 (32.9) 641 (36.3)
Mediterranean diet þ Nuts 2301 (32.6) 562 (31.9) 556 (31.6) 599 (33.8) 584 (33.1)
Control diet 2328 (33.0) 614 (34.8) 585 (33.3) 589 (33.3) 540 (30.6)
Aspirin intake, n (%) 1577 (22.3) 1375 (77.9) 1382 (78.7) 1374 (77.6) 1348 (76.4) 0.428
Vitamin supplements, n (%) 761 (10.8) 166 (9.4) 174 (9.9) 185 (10.5) 236 (13.4) 0.001
Hormone replacement therapy, n (%) 112 (1.6) 27 (1.5) 31 (1.8) 31 (1.8) 23 (1.3) 0.658
Mediterranean diet score 8.7 (1.9) 8.3 (1.8) 8.6 (1.9) 8.8 (1.9) 9.0 (1.9) <0.001
Continuous variables are expressed as means (SD) and categorical variables as number (percent).
Abbreviations: MET, metabolic equivalent tasks; EVOO, extra-virgin olive oil.
a Differences for participants of total sugar intake quartiles by ANOVA or chi-square as appropriate.
Table 2
Simple Sugars by Source at Baseline According to the Median of Sugar Intake quartiles.
Grams/day Total 47 g/day >47 to 62.2 g/day >62.2 to 81.8 g/day >81.8 g/day
No. of participants 7056 1764 1757 1770 1765
Liquid Glucose 0.3 (0.0e4.2) 0.1 (0.0e1.4) 0.3 (0.0e2.1) 0.6 (0.0e4.2) 0.8 (0.0e4.9)
Solid Fructose 33.5 (25.4e44.3) 20.4 (16.6e23.0) 29.7 (27.4e31.5) 38.2 (35.5e41.3) 52.4 (47.5e60.5)
Liquid Fructose 0.3 (0.0e4.3) 0.1 (0.0e2.0) 0.3 (0.0e2.4) 0.7 (0.0e4.3) 0.9 (0.0e6.1)
Fructose in Fruit Juice 0.0 (0.0e0.4) 0.0 (0.0e0.0) 0.0 (0.0e0.4) 0.0 (0.0e0.4) 0.0 (0.0e0.9)
Fructose in Fruits 14.1 (9.2e19.2) 7.5 (4.9e10.3) 12.8 (9.7e15.3) 16.4 (12.9e19.8) 22.7 (17.9e30.7)
Total Solid Sugar 62.2 (47.0e81.7) 38.0 (31.5e42.3) 54.8 (51.0e58.4) 71.3 (66.2e76.2) 97.2 (88.3e112.2)
Total Liquid Sugar 0.6 (0.0e8.6) 0.3 (0.0e3.4) 0.6 (0.0e4.7) 1.3 (0.0e8.6) 1.8 (0.0e10.5)
Total Sugar 67.0 (50.6e88.5) 40.3 (33.4e45.9) 57.5 (52.8e62.0) 74.8 (68.7e81.5) 104.6 (92.7e122.5)
Sugar intake is expressed as medians (interquartile ranges).
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replaced by MUFAs, solid sugars, or complex carbohydrates. Simple
sugars consumed in solid form, including fructose from fruit, were
unrelated to outcomes.
Epidemiological data supporting a relationship between
increased simple sugar intake and risk of cancer are scarce [12,13],
although an association with certain specific cancer sites has been
suggested. Thus, in the large European Prospective Investigation
into Cancer and Nutrition cohort [24], a positive association was
found between increased total sugar intake and risk of liver cancer.
Results from other large prospective studies, such as the NIH-AARP
Diet and Health Study, have suggested that free fructose con-
sumption significantly increased the risk of cancer of the small
intestine [25] and pancreas [26]. An association of fructose intake
with pancreatic cancer risk was also suggested in ameta-analysis of
10 cohort studies [27]. The large prospective NutriNet-Sante French
cohort provides suggestive evidence of the cancer-promoting
properties of SSBs [28], as sugary drink consumption was associ-
ated with total cancer risk (HR for a 100 mL/d increase of 1.18e95%
CI, 1.10e1.27), and with breast cancer risk (HR of 1.22e95% CI,
1.07e1.39). Of note, a similar association of fruit juice consumption5273with total cancer risk was observed per an increase of 100mL/d (HR
of 1.12e95% CI, 1.03e1.23). With HRs between 1.08 and 1.19 per 5 g/
d increments, the strength of the associations between total sugar,
glucose and fructose in liquid form and overall cancer found in our
study is similar to that of the NutriNet-Sante study for equivalent
100 mL/d increases in SSBs. Concerning fructose from 100% fruit
juice, our cancer risk estimate for a 5 g/d increase (HR, 1.39) nearly
tripled the effect size for a 100 mL/d increment reported in the
NutriNet-Sante study. However, a note of caution is necessary, since
there were few consumers of fruit juice in our cohort. In fact, a
marginal consumption of natural fruit juice has also been observed
in an older Spanish population with characteristics similar to those
of PREDIMED participants [29]. At any rate, a recent comprehensive
review concluded that there is no conclusive evidence that con-
sumption of 100% fruit juice has adverse health effects [30]. A
recent report from the same French study suggests an increased
overall cancer risk from total sugar intake, but the association was
driven exclusively by breast cancer [31].
Epidemiological evidence of increased cancer mortality from
sugar intake is inconclusive [14e16]. Our risk estimates for the
association between 5 g/day increases in intake of total liquid
Fig. 2. Association of intake of liquid sugars with cancer incidence and mortality, cardiovascular disease mortality, and all-cause mortality.
Multivariable Cox regression models stratified by recruiting center and adjusted for age, sex, history of diabetes (yes/no), history of hypertension (yes/no), history of dyslipidemia
(yes/no), smoking habit (never, current, and former), body mass index, total energy intake, physical activity (METs/min/day), aspirin intake (yes/no), vitamin supplementation (yes/
no), hormone replacement therapy (yes/no), family history of cancer (yes/no), salt intake (g/day), red meat consumption (g/day), processed meat consumption (g/day), adherence to
Mediterranean diet score (0e14), intervention group, and annual (time dependent variable) change in total sugar intake in g/day. The models were further adjusted for robust
variance estimators to account for small deviations from individual randomization.
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provided HRs ranging from 1.14 to 1.35, similar to those reported
from the large cohorts of Nurses’ Health Study and Health Pro-
fessionals Follow-up Study for SSBs [15]. The HR of fructose from
fruit juice for cancer mortality risk (1.75) was higher than that of
other liquid sugars, but again the data are based on low numbers of
consumers of fruit juice. In any case, these figures must be taken
with caution because cancermortality is a less robust outcome than
cancer incidence, as many patients with a cancer diagnosis die from
causes unrelated to cancer, particularly CVD [32].
Our results suggesting a modest increase in all-cause mortality
risk from liquid sugar intake concur with prior data on exposure to
sugary beverages from large US [14,15,33] and European [34] co-
horts. Of note, in the REGARDS study [33] the reported mortality
risk for fruit juice duplicated that ascribed to conventional SSBs,
which agrees with our data on fructose from fruit juice. Of interest,
consumption of table sugar, customarily used to sweeten beverages
or semiliquid foods, was also associated with all-cause mortality in
our study. SSB consumption has been associated with an increased
risk for CVDmortality among US adults [15,33,35], but we observed
no such associations in the PREDIMED cohort. Reflecting the
adherence of our older participants to a Mediterranean-style diet
[17], the intake of simple sugars in liquid form among them was
rather low, a reason why our study may not have had a wide
enough range to asses effects on relatively low numbers of fatal
CVD.
There is still discussion on the role of simple sugars in human
health, specifically whether they have a distinct deleterious effect
or are simply the vehicles for excess energy [36]. Our results
showing a significant association of simple sugar intakewith cancer
incidence and mortality, independently of energy intake and BMI,5274point to a specific harmful effect beyond the energy provided and
its consequences on adiposity. Another point of debate is whether
the physical form in which simple sugars are consumed influences
their clinical effects. Concerning weight gain, the prevailing evi-
dence suggests that intake of liquid calories in SSBs results in low
satiety indices and an incomplete compensatory reduction in en-
ergy intake at subsequent meals, which leads to passive energy
hyperconsumption [7]. Postprandial hyperglycemia induced by
intake of readily absorbable sugars in liquid form also leads to
hyperinsulinemia and related metabolic disturbances [37]. The
positive associations between liquid but not solid sugars and clin-
ical outcomes in our study concur with a harmful effect of liquid
sugars, which is further supported by the results of substitution
analyses of liquid sugars for other nutrients.
4.1. Strengths and limitations
Our study has several strengths, such as its prospective design,
large sample size, and relative long duration of follow-up.
Furthermore, we used yearly updated measures of simple sugar
intake from baseline to the last FFQ, a better approach than using a
single baseline FFQ because the participant's diet may have
changed during follow-up. Additionally, the availability of adjudi-
cated clinical events and the fact that most incident cancer di-
agnoses were based on histological or cytological data minimized
the risk of outcome misclassification. Finally, the data on cancer
incidence for most liquid sugars was consistent in both continuous
and doseeresponse models.
There are also limitations to our study. First, our results were
obtained in an older Mediterranean cohort at high cardiovascular
risk, thus may not be generalized to other populations. Second,
Table 3
HRs (95% CIs)a for cancer incidence and mortality and CVD and all-cause mortality by categories of intake of liquid sugars in the PREDIMED cohort.
Intake in grams/day
Non-consumers Tertile 1 Tertile 2 Tertile 3 P-linear trendb
Total liquid sugars 0 >0 to 1.9 >1.9 to 10.3 >10.3
No. of participants 3002 1375 1383 1296
Cancer incidence
Crude model 1.0 (ref) 0.97 (0.76e1.23) 1.08 (0.85e1.36) 1.31 (1.04e1.66) 0.011
Fully adjusted model 1.0 (ref) 1.03 (0.81e1.32) 1.19 (0.94e1.51) 1.46 (1.12e1.90) 0.004
Cancer mortality
Crude model 1.0 (ref) 0.79 (0.50e1.24) 1.10 (0.72e1.68) 1.07 (0.69e1.67) 0.575
Fully adjusted model 1.0 (ref) 0.89 (0.56e1.40) 1.33 (0.86e2.07) 1.38 (0.84e2.27) 0.152
CVD mortality
Crude model 1.0 (ref) 0.91 (0.54e1.55) 0.69 (0.39e1.21) 0.87 (0.50e1.51) 0.690
Fully adjusted model 1.0 (ref) 0.98 (0.58e1.67) 0.75 (0.43e1.33) 0.96 (0.54e1.74) 0.939
All-Cause mortality
Crude model 1.0 (ref) 0.83 (0.64e1.08) 0.82 (0.63e1.07) 0.87 (0.66e1.14) 0.478
Fully adjusted model 1.0 (ref) 0.96 (0.74e1.25) 0.99 (0.76e1.30) 1.15 (0.85e1.56) 0.311
Liquid glucose 0 >0 to 0.9 >0.9 to 4.49 >4.49
No. of participants 3002 1375 1344 1335
Cancer incidence
Crude model 1.0 (ref) 0.97 (0.76e1.24) 1.06 (0.84e1.33) 1.34 (1.07e1.69) 0.005
Fully adjusted model 1.0 (ref) 1.03 (0.81e1.32) 1.15 (0.91e1.47) 1.51 (1.17e1.96) 0.001
Cancer mortality
Crude model 1.0 (ref) 0.79 (0.50e1.24) 1.05 (0.68e1.63) 1.12 (0.72e1.73) 0.432
Fully adjusted model 1.0 (ref) 0.89 (0.56e1.40) 1.27 (0.81e1.99) 1.46 (0.90e2.39) 0.093
CVD mortality
Crude model 1.0 (ref) 0.91 (0.54e1.55) 0.67 (0.37e1.19) 0.89 (0.52e1.53) 0.770
Fully adjusted model 1.0 (ref) 0.97 (0.57e1.66) 0.72 (0.40e1.28) 1.04 (0.59e1.84) 0.841
All-Cause mortality
Crude model 1.0 (ref) 0.83 (0.64e1.07) 0.80 (0.61e1.05) 0.88 (0.67e1.16) 0.569
Fully adjusted model 1.0 (ref) 0.96 (0.74e1.25) 0.96 (0.73e1.26) 1.19 (0.89e1.60) 0.206
Liquid fructose 0 >0 to 1.0 >1.0 to 6.0 >6.0
No. of participants 3002 1325 1337 1392
Cancer incidence
Crude model 1.0 (ref) 0.93 (0.72e1.19) 1.18 (0.94e1.48) 1.25 (0.99e1.57) 0.033
Fully adjusted model 1.0 (ref) 0.98 (0.77e1.27) 1.29 (1.02e1.63) 1.37 (1.06e1.78) 0.013
Cancer mortality
Crude model 1.0 (ref) 0.78 (0.49e1.25) 0.98 (0.63e1.53) 1.19 (0.78e1.81) 0.273
Fully adjusted model 1.0 (ref) 0.88 (0.56e1.40) 1.20 (0.76e1.90) 1.58 (0.99e2.51) 0.035
CVD mortality
Crude model 1.0 (ref) 0.94 (0.56e1.60) 0.76 (0.43e1.32) 0.76 (0.43e1.34) 0.383
Fully adjusted model 1.0 (ref) 1.02 (0.60e1.73) 0.81 (0.46e1.42) 0.82 (0.45e1.48) 0.512
All-Cause mortality
Crude model 1.0 (ref) 0.80 (0.61e1.05) 0.78 (0.59e1.02) 0.93 (0.71e1.21) 0.919
Fully adjusted model 1.0 (ref) 0.93 (0.71e1.22) 0.96 (0.73e1.27) 1.22 (0.92e1.63) 0.126
Fructose in fruit juice 0 0> to 0.88 >0.88 to 2.8 >2.82
No. of participants 4988 601 816 651
Cancer incidence
Crude model 1.0 (ref) 0.75 (0.54e1.05) 1.16 (0.89e1.50) 1.11 (0.83e1.48) 0.253
Fully adjusted model 1.0 (ref) 0.79 (0.56e1.11) 1.26 (0.96e1.65) 1.30 (0.94e1.81) 0.035
Cancer mortality
Crude model 1.0 (ref) 0.56 (0.28e1.16) 1.11 (0.67e1.84) 1.22 (0.71e2.08) 0.356
Fully adjusted model 1.0 (ref) 0.62 (0.30e1.27) 1.29 (0.76e2.21) 1.36 (0.72e2.59) 0.221
CVD mortality
Crude model 1.0 (ref) 0.71 (0.34e1.49) 0.67 (0.34e1.34) 0.69 (0.31e1.53) 0.264
Fully adjusted model 1.0 (ref) 0.83 (0.39e1.76) 0.79 (0.39e1.62) 0.84 (0.38e1.86) 0.657
All-Cause mortality
Crude model 1.0 (ref) 0.72 (0.50e1.06) 0.86 (0.62e1.20) 0.89 (0.62e1.28) 0.490
Fully adjusted model 1.0 (ref) 0.83 (0.57e1.22) 1.05 (0.74e1.48) 1.02 (0.67e1.55) 0.825
Tertiles are for the subgroups of consumers of any liquid sugar.
a Multivariable Cox regression models stratified by recruiting center and adjusted for age, sex, history of diabetes (yes/no), history of hypertension (yes/no), history of
dyslipidemia (yes/no), smoking habit (never, current, and former), body mass index, total energy intake, physical activity (METs/min/day), aspirin intake (yes/no), vitamin
supplementation (yes/no), hormone replacement therapy (yes/no), family history of cancer (yes/no), salt intake (g/day), red meat consumption (g/day), processed meat
consumption (g/day), adherence to Mediterranean diet score (0e14), intervention group, and annual (time dependent variable) change in total sugar intake in g/day. The
models were further adjusted for robust variance estimators to account for small deviations from individual randomization.
b Tests for linear trend across quantiles were conducted by modeling the median value within each quantile.
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factors, we cannot rule out the existence of unknown con-
founders. Third, as reported for the general Spanish population,
particularly in older populations [38], there was a low range of
exposures to liquid sugars in our cohort, which might have
compromised finding associations for some outcomes. Fourth, we
examined the effect of 9 dietary exposures in relation to 45275outcomes, which increases the probability that some findings
might have occurred by chance. Finally, data were derived from
FFQs, which rely on self-reported dietary intake that is suscep-
tible to exposure misclassification. However, our FFQ was vali-
dated, with good correlation coefficients for reproducibility and
relative validity, similar to those of FFQs used in other prospec-
tive studies.
Table 4
Risk of cancer incidence and mortality associated with Isocaloric replacement of
liquid sugars with other nutrients.
HR (95% CI) P valuea
Cancer incidence
Saturated fatty acids 0.67 (0.48e0.96) 0.028
Trans fatty acids 1.16 (0.55e2.45) 0.695
Monounsaturated fatty acids 0.71 (0.56e0.90) 0.004
Polyunsaturated fatty acids 0.65 (0.48e0.86) 0.003
Total solid sugars 0.65 (0.51e0.81) <0.001
Complex carbohydrate 0.71 (0.57e0.87) 0.001
Alcohol 0.72 (0.58e0.90) 0.004
Cancer mortality
Saturated fatty acids 0.66 (0.35e1.22) 0.185
Trans fatty acids 0.90 (0.21e3.91) 0.883
Monounsaturated fatty acids 0.52 (0.33e0.82) 0.005
Polyunsaturated fatty acids 0.65 (0.41e1.05) 0.078
Total solid sugars 0.59 (0.38e0.91) 0.018
Complex carbohydrate 0.66 (0.45e0.96) 0.032
Alcohol 0.70 (0.48e1.04) 0.081
All nutrient replacements at 5% of energy, except trans fatty acids (1% of energy).
a Multivariable Cox regression models stratified by recruitment centre and
adjusted for sex, age, history of diabetes (yes/no), history of hypertension (yes/no),
history of dyslipidemia (yes/no), smoking habit (never, current and former), phys-
ical activity (METs/min/d), aspirin intake (yes/no), vitamin supplementation (yes/
no), BMI, family history of cancer (yes/no), salt intake (g/day), red meat consump-
tion (g/day), processed meat consumption (g/day), total energy intake, energy from
protein, adherence to Mediterranean diet score (0e14 points), and intervention
group. The models were further adjusted for intake of the substituted nutrients and
additionally adjusted for robust variance estimators to account for small deviations
from individual randomization.
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In this study, higher intake of simple sugars in liquid form,
specifically total sugar, glucose and fructose, was associated with
increased cancer incidence and mortality and all-cause mortality
among older Mediterranean adults. Significantly lower cancer
incidence and mortality were observed when liquid sugars were
replaced by MUFAs, solid sugars, or complex carbohydrate. While
further studies of large cohorts with long-term follow-up are
needed, our findings suggest that reduction in consumption of
sugary drinks could be an effective preventive measure to reduce
overall cancer incidence and mortality and all-cause mortality.
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